Molecules/CONCIZUMAB

CONCIZUMAB

Molecular Identity

AntibodyApprovedFirst approved 2024

Mechanism of action: Tissue factor pathway inhibitor inhibitor

Molecular Formula

0.00

Molecular Weight

g/mol

ALHEMOAnti-TFPICONCIZUMABCONCIZUMAB-MTCImAb2021MAB-2021NN-7415NN7415NNC 0172-0000-2021NNC-0172-0000-2021NNC0172-2021NNC01722021NNC172-2021

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Trials and conditions connected to CONCIZUMAB

Loading drug network...